References
- Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, et al. Randomised double-blind comparison of chimeric mono-clonal antibody to tumour necrosis factor-alpha versus placebo in rheumatoid arthritis. Lancet. 1994;344:1105–10.
- Lovell DJ,Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Eng J Med. 2000;342:763–9.
- Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: social function, relationships and sexual activity. Rheumatology. 2002;41:1440–3.
- Chambers CD, Tutuncu ZN, Johnson D, Johns KL. Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data. Arthritis Res Ther. 2006;8:225.
- Lewden B, Vial T, Elefant E, Nelva A, Carlier P, Descotes J. French Network of Regional Pharmacovigilance Centers. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. J Rheumatol. 2000;27:1872–5.
- Lloyd ME, Carr M, McElhatton P, Hall GM, Hughes RA. The effects of methotrexate on pregnancy, fertility and lactation. Q J Med. 1999;92:551–63.
- Cush JJ. Biological drug use: US perspectives on indications and monitoring. Ann Rheum Dis. 2005;64:18–23.
- Ostensen M, Raio L. A woman with rheumatoid arthritis whose condition did not improve during pregnancy. Nat Clin Pract Rheumatol. 2005;1:111–4.
- Chambers CD, Johnson D, Jones KL, The OTIS Collaborative Group. Pregnancy outcome in women exposed to anti-TNF-a medications: the OTIS Rheumatoid Arthritis in Pregnancy Study (Abstract). Arthritis Rheum. 2004;50:479–80.
- Joven BE, Garcia-Gonzalez AJ, Ruiz T, Moreno E, Cebrian L, Valero M, et al. Pregnancy in women receiving anti-TNF-alpha therapy. Experience in Spain. (Abstract). Arthritis Rheum. 2005;52:5349.
- Mahadevan U, Kane S, Sandborn J, Cohen RD, Hansen K, Ter-diman JP, et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Ali-ment Pharmacol Ther. 2005;21:733–8.
- Simister NE. Placental transport of immunoglobulin G. Vaccine. 2003;21:3365–9.
- van Vollenhoven RF. Switching between biological agents. Clin Exp Rheumatol. 2004;22:S115–21.
- Cheifetz A, Smedley M, Martin S, Reiter M, Leone G, Mayer L, Plevy S. The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol. 2003;98:1315–24.
- Sugiura F, Kojima T, Oba M, Tsuchiya H, Ishiguro N. Anaphy-lactic reaction to infliximab in two rheumatoid arthritis patients who had previously received infliximab and resumed. Mod Rheumatol. 2005;15:201–3.